Minodril (Minoxidil)

Minoxidil acts as a potassium channel opener, increasing blood flow to hair follicles by dilating dermal papilla vessels. This enhanced circulation prolongs the anagen (growth) phase of the hair cycle, supporting follicle health and promoting the emergence of thicker hair shafts.

The specific dose and frequency of Minodril are determined by the prescribing clinician based on the patient’s condition, scalp area, and response. The prescriber will provide individualized instructions for the amount to apply and how often.

Safety of topical minoxidil in pregnancy and lactation has not been firmly established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Minodril.

To request Minodril, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minodril (topical minoxidil) works by increasing scalp blood flow and prolonging the hair‑growth phase, while finasteride is an oral 5‑α‑reductase inhibitor that reduces dihydrotestosterone levels. Minodril is applied locally and is often used when systemic therapy is not desired; finasteride targets hormonal pathways and may be more effective for some men but carries different systemic risks.

Store Minodril at temperatures below 25 °C in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight, and extreme heat to maintain product stability and efficacy.

Minodril is applied directly to a clean, dry scalp. The prescriber will advise the amount (typically a few drops) to spread over the affected area, usually twice daily. Hands should be washed after application, and the product should not be applied to broken or irritated skin.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis or angioedema, rapid heart rate (tachycardia), chest pain, and significant swelling of the face or lips. Any signs of systemic cardiovascular effects or severe skin reactions require immediate medical attention.

Minodril should be avoided by individuals with known hypersensitivity to minoxidil or any formulation components, those with active scalp infections, severe cardiovascular disease without medical supervision, and pregnant or nursing women unless a healthcare professional determines the benefits outweigh potential risks.